150 related articles for article (PubMed ID: 35455272)
1. Development of a Subunit Vaccine against Duck Hepatitis A Virus Serotype 3.
Truong TN; Cheng LT
Vaccines (Basel); 2022 Mar; 10(4):. PubMed ID: 35455272
[TBL] [Abstract][Full Text] [Related]
2. Oral vaccine of recombinant Lactococcus lactis expressing the VP1 protein of duck hepatitis A virus type 3 induces mucosal and systemic immune responses.
Song S; Li P; Zhang R; Chen J; Lan J; Lin S; Guo G; Xie Z; Jiang S
Vaccine; 2019 Jul; 37(31):4364-4369. PubMed ID: 31227355
[TBL] [Abstract][Full Text] [Related]
3. Live Attenuated Vaccine Based on Duck Enteritis Virus against Duck Hepatitis A Virus Types 1 and 3.
Zou Z; Ma J; Huang K; Chen H; Liu Z; Jin M
Front Microbiol; 2016; 7():1613. PubMed ID: 27777571
[TBL] [Abstract][Full Text] [Related]
4. Protection against duck hepatitis a virus type 1 conferred by a recombinant avian adeno-associated virus.
Wang AP; Liu L; Gu LL; Guo CM; Wu S; Feng Q; Xia WL; Wu Z; Zhu SY
Poult Sci; 2019 Jan; 98(1):112-118. PubMed ID: 30053293
[TBL] [Abstract][Full Text] [Related]
5. Construction of Recombinant
Zhang X; Zhang R; Wang J; Sui N; Xu G; Yan H; Zhu Y; Xie Z; Jiang S
Vaccines (Basel); 2021 Dec; 9(12):. PubMed ID: 34960225
[TBL] [Abstract][Full Text] [Related]
6. Detection, differentiation, and VP1 sequencing of duck hepatitis A virus type 1 and type 3 by a 1-step duplex reverse-transcription PCR assay.
Wen XJ; Cheng AC; Wang MS; Jia RY; Zhu DK; Chen S; Liu MF; Liu F; Chen XY
Poult Sci; 2014 Sep; 93(9):2184-92. PubMed ID: 25012848
[TBL] [Abstract][Full Text] [Related]
7. Protective efficacy of a bivalent live attenuated vaccine against duck hepatitis A virus types 1 and 3 in ducklings.
Kang M; Roh JH; Jang HK
Vet Microbiol; 2018 Feb; 214():108-112. PubMed ID: 29408021
[TBL] [Abstract][Full Text] [Related]
8. Self-Assembling Nanovaccine Fused with Flagellin Enhances Protective Effect against Foot-and-Mouth Disease Virus.
Pei C; Dong H; Teng Z; Wei S; Zhang Y; Yin S; Tang J; Sun S; Guo H
Vaccines (Basel); 2023 Nov; 11(11):. PubMed ID: 38006007
[TBL] [Abstract][Full Text] [Related]
9. Evidence of VP1 of duck hepatitis A type 1 virus as a target of neutralizing antibodies and involving receptor-binding activity.
Li X; Zhao R; Lin W; Li C; Zhang T; Meng F; Liu M; Zhang Y
Virus Res; 2017 Jan; 227():240-244. PubMed ID: 27816429
[TBL] [Abstract][Full Text] [Related]
10. Dual Circulation of Duck Hepatitis A Virus Genotypes 1 and 3 in Egypt.
Yehia N; Erfan AM; Omar SE; Soliman MA
Avian Dis; 2021 Mar; 65(1):1-9. PubMed ID: 34339115
[TBL] [Abstract][Full Text] [Related]
11. High yield expression of duck hepatitis A virus VP1 protein in Escherichia coli, and production and characterization of polyclonal antibody.
Li C; Chen Z; Meng C; Li L; Liu G
J Virol Methods; 2013 Jul; 191(1):69-75. PubMed ID: 23583731
[TBL] [Abstract][Full Text] [Related]
12. Identification of a conserved B-cell epitope on duck hepatitis A type 1 virus VP1 protein.
Wu X; Li X; Zhang Q; Wulin S; Bai X; Zhang T; Wang Y; Liu M; Zhang Y
PLoS One; 2015; 10(2):e0118041. PubMed ID: 25706372
[TBL] [Abstract][Full Text] [Related]
13. Molecular Evolution and Genetic Analysis of the Major Capsid Protein VP1 of Duck Hepatitis A Viruses: Implications for Antigenic Stability.
Ma X; Sheng Z; Huang B; Qi L; Li Y; Yu K; Liu C; Qin Z; Wang D; Song M; Li F
PLoS One; 2015; 10(7):e0132982. PubMed ID: 26173145
[TBL] [Abstract][Full Text] [Related]
14. Genetic variation of the VP1 gene of the virulent duck hepatitis A virus type 1 (DHAV-1) isolates in Shandong province of China.
Gao J; Chen J; Si X; Xie Z; Zhu Y; Zhang X; Wang S; Jiang S
Virol Sin; 2012 Aug; 27(4):248-53. PubMed ID: 22899433
[TBL] [Abstract][Full Text] [Related]
15. Comparative Pathogenicity of Duck Hepatitis A Virus-1 Isolates in Experimentally Infected Pekin and Muscovy Ducklings.
Hisham I; Ellakany HF; Selim AA; Abdalla MAM; Zain El-Abideen MA; Kilany WH; Ali A; Elbestawy AR
Front Vet Sci; 2020; 7():234. PubMed ID: 32671102
[TBL] [Abstract][Full Text] [Related]
16. Identification of a conserved neutralizing linear B-cell epitope in the VP1 proteins of duck hepatitis A virus type 1 and 3.
Zhang R; Zhou G; Xin Y; Chen J; Lin S; Tian Y; Xie Z; Jiang S
Vet Microbiol; 2015 Nov; 180(3-4):196-204. PubMed ID: 26427545
[TBL] [Abstract][Full Text] [Related]
17. First Report of Duck Hepatitis A Virus 3 from Duckling Flocks of Egypt.
Hassan TIR; Eid AAM; Ghanem IAI; Shahin AM; Adael SAA; Mohamed FF
Avian Dis; 2020 Sep; 64(3):269-276. PubMed ID: 33205161
[TBL] [Abstract][Full Text] [Related]
18. Development of duck hepatitis A virus type 3 vaccine and its use to protect ducklings against infections.
Kim MC; Kim MJ; Kwon YK; Lindberg AM; Joh SJ; Kwon HM; Lee YJ; Kwon JH
Vaccine; 2009 Nov; 27(48):6688-94. PubMed ID: 19747575
[TBL] [Abstract][Full Text] [Related]
19. [Development and evaluation of an inactivated bivalent vaccine against duck viral hepatitis].
Yin F; Jing L; Zhang S; Yu M; Zhang W; Fan G; Dong X; Liu W
Sheng Wu Gong Cheng Xue Bao; 2015 Nov; 31(11):1579-88. PubMed ID: 26939441
[TBL] [Abstract][Full Text] [Related]
20. Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus.
Wu CN; Lin YC; Fann C; Liao NS; Shih SR; Ho MS
Vaccine; 2001 Dec; 20(5-6):895-904. PubMed ID: 11738755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
